1.

The DePauw, November 17, 2006

2.

The DePauw, November 17, 2006

3.

The DePauw, November 17, 2006

1.

Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.

2.

Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.

3.

Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.

4.

Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.

5.

Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.

6.

Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.

7.

Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.

8.

Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.

9.

Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.

1.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

2.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

3.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

4.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

5.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

6.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

7.

The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia : an expert survey in breast cancer...

1.

Management and outcome of high-risk peritonitis: a retrospective survey 2005-2009.

2.

Management and outcome of high-risk peritonitis: a retrospective survey 2005-2009.

3.

Management and outcome of high-risk peritonitis: a retrospective survey 2005-2009.

1.

De briques et de bois: contribution à l'histoire de l'architecture à Bruxelles :étude archéologique, technique et historique des matériaux de construction, XIII - XVIIIe siècle ; F...

2.

De briques et de bois: contribution à l'histoire de l'architecture à Bruxelles :étude archéologique, technique et historique des matériaux de construction, XIII - XVIIIe siècle ; F...

3.

De briques et de bois: contribution à l'histoire de l'architecture à Bruxelles :étude archéologique, technique et historique des matériaux de construction, XIII - XVIIIe siècle ; F...

4.

De briques et de bois: contribution à l'histoire de l'architecture à Bruxelles :étude archéologique, technique et historique des matériaux de construction, XIII - XVIIIe siècle ; F...

5.

De briques et de bois: contribution à l'histoire de l'architecture à Bruxelles :étude archéologique, technique et historique des matériaux de construction, XIII - XVIIIe siècle ; F...

6.

De briques et de bois: contribution à l'histoire de l'architecture à Bruxelles :étude archéologique, technique et historique des matériaux de construction, XIII - XVIIIe siècle ; F...

7.

De briques et de bois: contribution à l'histoire de l'architecture à Bruxelles :étude archéologique, technique et historique des matériaux de construction, XIII - XVIIIe siècle ; F...

1.

Equine ulcerative keratitis in Belgium: Associated bacterial isolates and in vitro antimicrobial resistance in 200 eyes.

2.

Equine ulcerative keratitis in Belgium: Associated bacterial isolates and in vitro antimicrobial resistance in 200 eyes.

3.

Equine ulcerative keratitis in Belgium: Associated bacterial isolates and in vitro antimicrobial resistance in 200 eyes.

4.

Equine ulcerative keratitis in Belgium: Associated bacterial isolates and in vitro antimicrobial resistance in 200 eyes.

5.

Equine ulcerative keratitis in Belgium: Associated bacterial isolates and in vitro antimicrobial resistance in 200 eyes.

6.

Equine ulcerative keratitis in Belgium: Associated bacterial isolates and in vitro antimicrobial resistance in 200 eyes.

7.

Equine ulcerative keratitis in Belgium: Associated bacterial isolates and in vitro antimicrobial resistance in 200 eyes.

1.

Notes and Queries - volume 8, 3rd Series - Page 170

2.

Notes and Queries - volume 8, 3rd Series - Page 170

3.

Notes and Queries - volume 8, 3rd Series - Page 170

1.

Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study.

2.

Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study.

3.

Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study.

1.

Notes and Queries - volume 6, 3rd Series - Page 9

2.

Notes and Queries - volume 6, 3rd Series - Page 9

3.

Notes and Queries - volume 6, 3rd Series - Page 9

1.

Increased prevalence of ECG markers for sudden cardiac arrest in refractory epilepsy.

2.

Increased prevalence of ECG markers for sudden cardiac arrest in refractory epilepsy.

3.

Increased prevalence of ECG markers for sudden cardiac arrest in refractory epilepsy.